Avaxia Biologics
company
About
Avaxia Biologics develops orally-delivered antibody therapeutics using a proprietary antibody platform.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $6.40M
- Industries
- Biotechnology,Medical Device,Therapeutics
- Founded date
- Jan 1, 2005
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity.
Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$22M
Avaxia Biologics has raised a total of
$22M
in funding over 2 rounds. Their latest funding was raised on
Jun 7, 2013 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 7, 2013 | Series B | $11.50M | 2 | — | — | Detail |
| Dec 19, 2012 | Series B | $6.40M | 3 | — | — | Detail |
| Feb 14, 2012 | Series A | $4.10M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Avaxia Biologics is funded by 3 investors.
Granite State Angels
and North Country Angels
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Granite State Angels
|
— | Series B |
North Country Angels
|
— | Series B |
Keiretsu Forum
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
